Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 23;12:1758835920982853. doi: 10.1177/1758835920982853

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 3. — Higher levels of ATR and p-ATR were present in recurrent ovarian cancer tissues compared with patient-matched primary tumors, and strong p-ATR expression correlated with poor patient prognosis. (A) ATR staining scores among tissues taken from primary, synchronous metastatic, and metachronous recurrent tumors. (B, C) Correlation between ATR expression in the primary ovarian cancer tissues and OS (B) or PFS (C) in ovarian cancer patients by Kaplan–Meier survival analysis. (D). p-ATR staining scores distribution among the same tumor samples. (E, F) Relationship between p-ATR expression in the primary ovarian cancer tissues and OS (E) or PFS (F) in ovarian cancer patients by Kaplan–Meier survival analysis.

ATR, ataxia-telangiectasia and Rad3 related; OS, overall survival; p-ATR, phospho-ATR ser428; PFS, progression-free survival.